VERTEX PHARMACEUTICALS INC / MA Payments to Acquire Property, Plant, and Equipment in USD from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from Q1 2010 to Q1 2025.
  • Vertex Pharmaceuticals Inc / Ma Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $40.7M, a 40.5% decline year-over-year.
  • Vertex Pharmaceuticals Inc / Ma annual Payments to Acquire Property, Plant, and Equipment for 2024 was $298M, a 48.6% increase from 2023.
  • Vertex Pharmaceuticals Inc / Ma annual Payments to Acquire Property, Plant, and Equipment for 2023 was $200M, a 2.1% decline from 2022.
  • Vertex Pharmaceuticals Inc / Ma annual Payments to Acquire Property, Plant, and Equipment for 2022 was $205M, a 12.9% decline from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $40.7M -$27.7M -40.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $68.4M +$26.3M +62.5% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q1 2023 $42.1M -$21.5M -33.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $63.6M -$7.3M -10.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q1 2021 $70.9M +$51.5M +265% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2020 $19.5M +$1.41M +7.81% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q1 2019 $18M -$11.2M -38.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q1 2018 $29.3M +$18.2M +164% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q1 2017 $11.1M -$875K -7.31% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q1 2016 $12M +$1.42M +13.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q1 2015 $10.6M -$4.97M -32% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q1 2014 $15.5M -$1.08M -6.51% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
Q1 2013 $16.6M +$10.5M +170% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q1 2012 $6.16M +$1.31M +26.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q1 2011 $4.85M +$1.74M +55.9% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q1 2010 $3.11M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06

VERTEX PHARMACEUTICALS INC / MA Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $298M +$97.3M +48.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-13
2023 $200M -$4.3M -2.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-13
2022 $205M -$30.3M -12.9% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-13
2021 $235M -$24.8M -9.55% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $260M +$184M +245% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 $75.4M -$20M -21% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-09
2018 $95.4M -$3.97M -4% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $99.4M +$42.9M +75.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 $56.6M +$11.3M +24.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-13
2015 $45.3M -$5.9M -11.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-15
2014 $51.2M -$192K -0.37% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 $51.4M -$19.7M -27.8% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-16
2012 $71.1M +$36.5M +106% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-13
2011 $34.6M -$3.46M -9.09% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-11
2010 $38.1M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.